01 8AmBisome
02 14Ambisome
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 436
2019 Revenue in Millions : 407
Growth (%) : 7
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 36
2019 Revenue in Millions : 40
Growth (%) : -12
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 112
2019 Revenue in Millions : 110
Growth (%) : 2
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 139
2020 Revenue in Millions : 111
Growth (%) : 35
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 540
2020 Revenue in Millions : 436
Growth (%) : 24
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 115
2021 Revenue in Millions : 138
Growth (%) : -17
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 497
2021 Revenue in Millions : 540
Growth (%) : -8
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 492
2022 Revenue in Millions : 497
Growth (%) : -1
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2018 Revenue in Millions : 115
2017 Revenue in Millions : 97
Growth (%) : 18%
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2016 Revenue in Millions : 95
2015 Revenue in Millions : 95
Growth (%) : -1
LOOKING FOR A SUPPLIER?
